Article Text

Download PDFPDF

Occupation and male infertility: glycol ethers and other exposures
  1. N Cherry1,
  2. H Moore2,
  3. R McNamee1,
  4. A Pacey2,
  5. G Burgess1,
  6. J-A Clyma1,
  7. M Dippnall1,
  8. H Baillie2,
  9. A Povey1,
  10. participating centres of Chaps-UK
  1. 1
    Centre for Occupational and Environmental Health, University of Manchester, UK
  2. 2
    Academic Unit of Reproductive and Developmental Medicine, University of Sheffield, UK
  1. Nicola Cherry, Community and Occupational Medicine Program, 13-103 Clinical Sciences Building, University of Alberta, Edmonton Alberta, Canada T6G 2G3; nicola.cherry{at}ualberta.ca

Footnotes

  • Funding: The study was funded by the UK Health and Safety Executive, the UK Department of Environment, Transport and the Regions, the UK Department of Health and the European Chemical Industry Council. The views expressed are those of the authors and not necessarily those of the funding bodies.

  • Competing interests: None.

  • Ethics approval: Ethical approval was given by the Multi-Centre Ethics Committee for the North West (ref. no. MREC 98/8/73) with subsequent approval given by the Local Research Ethics Committee at each site.

  • Participating centres of Chaps-UK: Department of Obstetrics and Gynaecology, Queens University, Belfast; Assisted Conception Unit, Birmingham Women’s Hospital; Division of Obstetrics and Gynaecology, St Michael’s Hospital, Bristol; Directorate of Women’s Health, Southmead Hospital, Bristol; Cardiff Assisted Reproduction Unit, University of Wales; MRC Reproductive Biology Unit, Edinburgh; Reproductive Medicine Unit, Liverpool Women’s Hospital; St Bartholomew’s Hospital, London; Department of Obstetrics and Gynaecology, Royal Free and University College, London; Department of Reproductive Medicine, St Mary’s Hospital, Manchester; IVF/Immunology Laboratory, Hope Hospital, Salford; Department of Histopathology, Wythenshawe Hospital, Manchester; International Centre for Life, Newcastle; Department of Obstetrics and Gynaecology, Jessop Hospital for Women, Sheffield; Shropshire and Mid-Wales Fertility Centre, Royal Shrewsbury NHS Trust.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Funding: The study was funded by the UK Health and Safety Executive, the UK Department of Environment, Transport and the Regions, the UK Department of Health and the European Chemical Industry Council. The views expressed are those of the authors and not necessarily those of the funding bodies.

  • Competing interests: None.

  • Ethics approval: Ethical approval was given by the Multi-Centre Ethics Committee for the North West (ref. no. MREC 98/8/73) with subsequent approval given by the Local Research Ethics Committee at each site.

  • Participating centres of Chaps-UK: Department of Obstetrics and Gynaecology, Queens University, Belfast; Assisted Conception Unit, Birmingham Women’s Hospital; Division of Obstetrics and Gynaecology, St Michael’s Hospital, Bristol; Directorate of Women’s Health, Southmead Hospital, Bristol; Cardiff Assisted Reproduction Unit, University of Wales; MRC Reproductive Biology Unit, Edinburgh; Reproductive Medicine Unit, Liverpool Women’s Hospital; St Bartholomew’s Hospital, London; Department of Obstetrics and Gynaecology, Royal Free and University College, London; Department of Reproductive Medicine, St Mary’s Hospital, Manchester; IVF/Immunology Laboratory, Hope Hospital, Salford; Department of Histopathology, Wythenshawe Hospital, Manchester; International Centre for Life, Newcastle; Department of Obstetrics and Gynaecology, Jessop Hospital for Women, Sheffield; Shropshire and Mid-Wales Fertility Centre, Royal Shrewsbury NHS Trust.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.